HR+/HER2- early breast cancer

Clinical trials for HR+/HER2- early breast cancer explained in plain language.

Never miss a new study

Get alerted when new HR+/HER2- early breast cancer trials appear

Sign up with your email to follow new studies for HR+/HER2- early breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 3 Not yet finished but already full! 1 Completed 1

Could a pill replace chemo for some breast cancer patients?

Disease control Ongoing

This study tests if a combination of ribociclib (a targeted pill) and hormone therapy works better than standard chemotherapy for women with a common type of early breast cancer (HR+/HER2-). About 1,684 women with intermediate-risk disease are taking part. The goal is to see whic…

Matched conditions: HR+/HER2- EARLY BREAST CANCER

Phase 3 • Sponsor: West German Study Group • Aim: Disease control

Last updated Jun 27, 2026 12:31 UTC

HR+/HER2- early breast cancer

Get alerted when new HR+/HER2- early breast cancer trials appear

Could a pill replace chemo for some breast cancer patients?